Cite
HARVARD Citation
Michels, G. et al. (n.d.). A blinded, randomized, placebo‐controlled, dose determination trial of lokivetmab (ZTS‐00103289), a caninized, anti‐canine IL‐31 monoclonal antibody in client owned dogs with atopic dermatitis. Veterinary dermatology. 27 (6), pp. 478-e129. [Online].